NRG1 and Parkinson disease: Compared to healthy individuals, transcript levels of the pleiotrophic growth factor neuregulin 1 (NRG1) decreased by 50% in the NDD-D group (p < 0.05) (Figure 3A), and by 80% in NDD-PD patients (p < 0.01) (Figure 3B).